The abstract is read at the publisher; the summary is JClub's.
Only 41 of 186 countries (22%) in GLOBOCAN 2024 have independent mortality-to-incidence ratios, all in high/very high HDI, with site fractions from 0.12 to 0.77.
- Why it matters: MIR comparisons across countries can be misleading when incidence and mortality are estimated from different sources or one component is derived from the other.
- What they did: Using GLOBOCAN 2024, countries were labeled independent when incidence came from registries and mortality was observed, then MIR–HDI Spearman correlations were compared across 37 cancer sites.
- The result: For 33 of 37 sites, MIR–HDI correlations in independent-MIR countries matched what HDI range restriction alone predicts, but thyroid’s association weakened beyond that ({rho} -0.82 to -0.004, adjusted p = 0.011).
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.